Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Lyell Immunopharma, Inc. (LYEL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Klausner Richard (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Sold 58,020 shares @ $2.28, valued at $132.3k
08/11/2023 4 Lang Matthew (Chief Business Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 2,250,000 options to buy @ $2.31, valued at $5.2M
07/20/2023 3 Lang Matthew (Chief Business Officer) has filed a Form 3 on Lyell Immunopharma, Inc.
02/28/2023 4 Hill Stephen J. (Chief Technical Ops. Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 900,000 options to buy @ $2.13, valued at $1.9M
02/28/2023 4 Albertson Tina M. (Chief Medical Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 700,000 options to buy @ $2.13, valued at $1.5M
02/28/2023 4 Lee Gary K. (Chief Scientific Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 600,000 options to buy @ $2.13, valued at $1.3M
02/28/2023 4 Thompson Rahsaan (Chief Legal Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 245,000 options to buy @ $2.13, valued at $521.9k
02/28/2023 4 Newton Charles W. (CFO) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 700,000 options to buy @ $2.13, valued at $1.5M
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2022 4 Thompson Rahsaan (Chief Legal Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 715,000 options to buy @ $6.91, valued at $4.9M
10/03/2022 3 Thompson Rahsaan (Chief Legal Officer) has filed a Form 3 on Lyell Immunopharma, Inc.
09/27/2022 4 Klausner Richard (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Sold 11,100 shares @ $6.4001, valued at $71k
09/09/2022 4 Bishop Hans Edgar (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Exercised 145,380 options to buy @ $0.1, valued at $14.5k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 BRAWLEY OTIS W (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 65,000 options to buy @ $5.31, valued at $345.2k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2022 3 Albertson Tina M. (Chief Medical Officer) has filed a Form 3 on Lyell Immunopharma, Inc.
03/18/2022 4 Turner Heather D (Chief General Counsel) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 300,000 options to buy @ $5.98, valued at $1.8M
03/18/2022 4 Newton Charles W. (CFO) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 500,000 options to buy @ $5.98, valued at $3M
03/18/2022 4 Homans Elizabeth (CEO) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 1,479,500 options to buy @ $5.98, valued at $8.8M
03/18/2022 4 Hill Stephen J. (Chief Technical Ops. Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 700,000 options to buy @ $5.98, valued at $4.2M
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Lee Gary K. (Chief Scientific Officer) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 800,000 options to buy @ $6.04, valued at $4.8M
02/04/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2021 4 Homans Elizabeth (CEO) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Granted 1,370,469 options to buy @ $16.05, valued at $22M
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy